Home/Regenesis/Frank George, PhD

FG

Frank George, PhD

Co-Founder

Therapeutic Areas

Chronic Pain Musculoskeletal Disorders Diabetic Neuropathy

Regenesis Pipeline

Drug	Indication	Phase
Reprieve for Diabetic Peripheral Neuropathy	Diabetic Peripheral Neuropathy Pain	Post-Market
Reprieve for Plantar Fasciitis	Plantar Fasciitis Pain	Post-Market
Reprieve for Musculoskeletal Pain	General Musculoskeletal Pain (e.g., Lumbar)	Post-Market

Leadership Team at Regenesis

Tom Eisiminger, Jr.

President & Chief Executive Officer

Vice President and Chief Financial Officer

Erica Tassone, PhD

Vice President, Research & Development

Co-Founder, former President & CEO

View full Regenesis profile